Potential COVID-19 treatment to kick off Phase III trial October 26, 2021 Auto Bot Clinical Development 0 Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.
